Monoclonal antibodies (Mabs) are of increasing importance in the treatment of cancers and autoimmune conditions such as non-Hodgkin's lymphoma (NHL) and rheumatoid arthritis (RA). However, some Mabs are more effective than others in targeting diseased cells.
Further information: cordis.europa.eu